In our current study, we have clearly shown that depletion of a large population of CD200R+ myeloid cells (Ly6G+) using anti-Gr1 mAb achieved a similar effect to CD200 expression on melanoma cells (Figure 3). The gene discussed is CD200R1; the disease is melanoma.